Skip to Content

Trastuzumab

In the US, Trastuzumab (trastuzumab systemic) is a member of the drug class HER2 inhibitors and is used to treat Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Metastatic, Esophageal Carcinoma, Gastric Cancer and Salivary Gland Cancer.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XC03

CAS registry number (Chemical Abstracts Service)

0180288-69-1

Chemical Formula

C6470-H10012-N1726-O2013-S42

Therapeutic Categories

Antineoplastic agent

Biological response modifier, BRM

Immunomodulator

Anti-HER2 monoclonal antibody

Chemical Name

Immunoglobulin G1 (human-mouse monoclonal rhuMab HER2γ₁-chain antihuman p185c-erbB²receptor), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer (WHO )

Foreign Names

  • Trastuzumabum (Latin)
  • Trastuzumab (German)
  • Trastuzumab (French)
  • Trastuzumab (Spanish)

Generic Names

Brand Names

  • Herceptin
    Chugai Pharmaceutical, Japan; Dr. F. Hoffmann-Lja - Roche, Russian Federation; F. Hoffmann-La Roche LTD, Serbia; Genentech, United States; Haemato Pharm, Austria; Hoffmann-La Roche, Bosnia & Herzegowina; Hoffmann-La Roche Ltd, Latvia; Inopha, Austria; Productos Roche, Chile; Roche, Armenia; Roche, Argentina; Roche, Australia; Roche, Bangladesh; Roche, Belgium; Roche, Brazil; Roche, Canada; Roche, China; Roche, Colombia; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Ecuador; Roche, Egypt; Roche, Spain; Roche, Finland; Roche, France; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Hungary; Roche, Indonesia; Roche, Ireland; Roche, Israel; Roche, Iceland; Roche, Italy; Roche, Lebanon; Roche, Lithuania; Roche, Moldova; Roche, Myanmar; Roche, Mexico; Roche, Netherlands; Roche, Norway; Roche, New Zealand; Roche, Oman; Roche, Philippines; Roche, Poland; Roche, Portugal; Roche, Romania; Roche, Sweden; Roche, Slovenia; Roche, Thailand; Roche, Turkey; Roche, Taiwan; Roche, Uruguay; Roche, Venezuela; Roche, Vietnam; Roche, South Africa; Roche Products, United Kingdom; Roche Registration, Austria
  • Herceptin SC
    Productos Roche, Chile
  • Hertin
    Techno, Bangladesh
  • Kadcyla
    Hoffmann-La Roche, Bosnia & Herzegowina; Productos Roche, Chile; Roche, Croatia (Hrvatska); Roche, Iceland; Roche, Poland; Chugai Pharmaceutical, Japan; DSM Pharmaceuticals, Georgia; Genentech, United States; Roche, Australia; Roche, Belgium; Roche, Germany; Roche, Denmark; Roche, Finland; Roche, France; Roche, Hong Kong; Roche, Hungary; Roche, Ireland; Roche, Israel; Roche, Italy; Roche, Mexico; Roche, Norway; Roche, New Zealand; Roche, Sweden; Roche, Slovenia; Roche Products, United Kingdom

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide